Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abbott Laboratories
A A C A A
A61P A61P C07D A61P A61P
inventional inventional inventional inventional inventional
Akhteruzzaman Rolf David A. Liangjun Wenping Allan C. Michael D. Nobuhiko Hongmei Todd W. Robert J. David D. Rong Jason P. Tami J. Dale J. Curt S. Christopher E. Sherie VL. Darold L.
Molla Wagner Betebenner Lu He Krueger Tufano Iwasaki Mo Rockway Carrick Anderson Zhang Shanley Pilot-Matias Kempf Cooper Motter Masse Madigan